Wu Y, Ruef J, Rao G N, Patterson C, Runge M S
Division of Cardiology, University of Texas Medical Branch at Galveston, 301 University Boulevard, 9.138 Medical Research Building, Galveston, TX 77555-1064, USA.
Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1469-74. doi: 10.1042/bj3301469.
The mitogenic effects of thrombin are mediated by a G-protein-coupled receptor. Because the effects of thrombin are strongly influenced by the expression of its receptor, an understanding of its regulatory mechanisms is essential. To identify mechanisms of human thrombin receptor (HTR) gene regulation, a series of HTR-promoter-luciferase constructs were made and transfected into human microvascular endothelial cells for analysis. Deletion from bp -303 to -164 abolished reporter gene expression. Dimethyl sulphate treatment in vivo and DNase I footprinting in vitro demonstrated that a cluster of three GC box consensus sites was occupied, and electrophoretic mobility-shift assays established that Sp1 and Sp3 both bind to this 3' GC box cluster. We mutated each of the three GC boxes individually and all three collectively within this 3' cluster. Basal promoter activity was decreased to 46%, 78% and 29% of control for each of the GC boxes mutated individually, and to 6% when the three were mutated collectively. To test the individual abilities of Sp1 and Sp3 to activate or repress HTR transcription, we conducted co-transfection experiments with wild-type or mutated HTR-promoter-luciferase constructs. Co-transfection with Sp1 significantly augmented wild-type HTR promoter activity. Sp3 alone did not affect activity, and inhibited Sp1-mediated activation. Competition for shared binding sites by Sp1 and Sp3 might differentially regulate HTR expression in vascular endothelial cells.
凝血酶的促有丝分裂作用是由一种G蛋白偶联受体介导的。由于凝血酶的作用受其受体表达的强烈影响,因此了解其调控机制至关重要。为了确定人类凝血酶受体(HTR)基因的调控机制,构建了一系列HTR启动子-荧光素酶构建体,并将其转染到人微血管内皮细胞中进行分析。从bp -303至-164的缺失消除了报告基因的表达。体内硫酸二甲酯处理和体外DNase I足迹分析表明,三个GC盒共有位点的簇被占据,电泳迁移率变动分析确定Sp1和Sp3都与这个3' GC盒簇结合。我们分别对这个3'簇内的三个GC盒进行了单独突变以及全部三个一起突变。对于单独突变的每个GC盒,基础启动子活性分别降至对照的46%、78%和29%,当三个一起突变时降至6%。为了测试Sp1和Sp3激活或抑制HTR转录的个体能力,我们用野生型或突变型HTR启动子-荧光素酶构建体进行了共转染实验。与Sp1共转染显著增强了野生型HTR启动子活性。单独的Sp3不影响活性,并抑制Sp1介导的激活。Sp1和Sp3对共享结合位点的竞争可能会差异调节血管内皮细胞中HTR的表达。